Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

T lymphocyte responses to heterologous secondary dengue virus infections.

Rothman AL.

Ann N Y Acad Sci. 2009 Sep;1171 Suppl 1:E36-41. doi: 10.1111/j.1749-6632.2009.05055.x.

PMID:
19751400
2.

Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever.

Fink J, Gu F, Vasudevan SG.

Rev Med Virol. 2006 Jul-Aug;16(4):263-75. Review.

PMID:
16791836
3.

Immunopathological mechanisms in dengue and dengue hemorrhagic fever.

Green S, Rothman A.

Curr Opin Infect Dis. 2006 Oct;19(5):429-36. Review.

PMID:
16940865
4.

The pathology of dengue hemorrhagic fever.

Leong AS, Wong KT, Leong TY, Tan PH, Wannakrairot P.

Semin Diagn Pathol. 2007 Nov;24(4):227-36. Review.

PMID:
18085063
5.

Plasma leakage in dengue haemorrhagic fever.

Srikiatkhachorn A.

Thromb Haemost. 2009 Dec;102(6):1042-9. doi: 10.1160/TH09-03-0208. Review.

PMID:
19967133
6.

Immunopathogenesis of Dengue hemorrhagic fever.

Rothman AL, Ennis FA.

Virology. 1999 Apr 25;257(1):1-6. Review. No abstract available.

7.

Dengue hemorrhagic fever with special emphasis on immunopathogenesis.

Kurane I.

Comp Immunol Microbiol Infect Dis. 2007 Sep;30(5-6):329-40. Review.

PMID:
17645944
8.

Vascular endothelium: the battlefield of dengue viruses.

Basu A, Chaturvedi UC.

FEMS Immunol Med Microbiol. 2008 Aug;53(3):287-99. doi: 10.1111/j.1574-695X.2008.00420.x. Review.

9.

Immunity and immunopathology in dengue virus infections.

Kurane I, Ennis FE.

Semin Immunol. 1992 Apr;4(2):121-7. Review.

PMID:
1617166
10.

Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome.

Kurane I, Rothman AL, Livingston PG, Green S, Gagnon SJ, Janus J, Innis BL, Nimmannitya S, Nisalak A, Ennis FA.

Arch Virol Suppl. 1994;9:59-64. Review.

PMID:
8032282
11.

Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS).

Pang T, Cardosa MJ, Guzman MG.

Immunol Cell Biol. 2007 Jan;85(1):43-5. Review.

PMID:
17130899
12.

Dengue fever and dengue haemorrhagic fever: challenges of controlling an enemy still at large.

Kurane I, Takasaki T.

Rev Med Virol. 2001 Sep-Oct;11(5):301-11. Review.

PMID:
11590668
13.

Dengue and dengue haemorrhagic fever: implications of host genetics.

Chaturvedi U, Nagar R, Shrivastava R.

FEMS Immunol Med Microbiol. 2006 Jul;47(2):155-66. Review.

14.

Invited commentary: Dengue lessons from Cuba.

Vaughn DW.

Am J Epidemiol. 2000 Nov 1;152(9):800-3. Review.

15.

Immunopathogenesis of dengue virus infection.

Lei HY, Yeh TM, Liu HS, Lin YS, Chen SH, Liu CC.

J Biomed Sci. 2001 Sep;8(5):377-88. Review.

PMID:
11549879
16.

Nitric oxide in dengue and dengue haemorrhagic fever: necessity or nuisance?

Chaturvedi UC, Nagar R.

FEMS Immunol Med Microbiol. 2009 Jun;56(1):9-24. doi: 10.1111/j.1574-695X.2009.00544.x. Review.

17.

Immunology and immunopathogenesis of dengue disease.

Rothman AL.

Adv Virus Res. 2003;60:397-419. Review.

PMID:
14689699
18.

Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) in dengue virus infection.

Noisakran S, Perng GC.

Exp Biol Med (Maywood). 2008 Apr;233(4):401-8. doi: 10.3181/0707-MR-198. Review.

PMID:
18367628
19.

Understanding dengue pathogenesis: implications for vaccine design.

Stephenson JR.

Bull World Health Organ. 2005 Apr;83(4):308-14. Review.

20.

Dengue fever and dengue shock syndrome.

Morens DM.

Hosp Pract (Off Ed). 1982 Jul;17(7):103-7, 110-3. Review. No abstract available.

PMID:
6125466
Items per page

Supplemental Content

Support Center